Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144
Forns J, Esnaola M, Lopez-Vicente M, Suades-Gonzalez E, Alvarez-Pedrerol M, Julvez J, Grellier J, Sebastian-Galles N, Sunyer J. The n-back test and the attentional network task as measures of child neuropsychological development in epidemiological studies. Neuropsychology. 2014 Jul;28(4):519-29. doi: 10.1037/neu0000085
Lopez-Vicente M, Sunyer J, Forns J, Torrent M, Julvez J. Continuous Performance Test II outcomes in 11-year-old children with early ADHD symptoms: a longitudinal study. Neuropsychology. 2014 Mar;28(2):202-11. doi: 10.1037/neu0000048
Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.